JP2024545816A5 - - Google Patents

Info

Publication number
JP2024545816A5
JP2024545816A5 JP2024536438A JP2024536438A JP2024545816A5 JP 2024545816 A5 JP2024545816 A5 JP 2024545816A5 JP 2024536438 A JP2024536438 A JP 2024536438A JP 2024536438 A JP2024536438 A JP 2024536438A JP 2024545816 A5 JP2024545816 A5 JP 2024545816A5
Authority
JP
Japan
Prior art keywords
approximately
pharmaceutical composition
composition according
particles
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024536438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545816A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/062387 external-priority patent/WO2023119093A1/en
Publication of JP2024545816A publication Critical patent/JP2024545816A/ja
Publication of JP2024545816A5 publication Critical patent/JP2024545816A5/ja
Pending legal-status Critical Current

Links

JP2024536438A 2021-12-20 2022-12-16 エアロゾル薬物送達のための組成物、方法及びシステム Pending JP2024545816A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163291538P 2021-12-20 2021-12-20
US63/291,538 2021-12-20
PCT/IB2022/062387 WO2023119093A1 (en) 2021-12-20 2022-12-16 Compositions, methods and systems for aerosol drug delivery

Publications (2)

Publication Number Publication Date
JP2024545816A JP2024545816A (ja) 2024-12-12
JP2024545816A5 true JP2024545816A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=84829628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024536438A Pending JP2024545816A (ja) 2021-12-20 2022-12-16 エアロゾル薬物送達のための組成物、方法及びシステム

Country Status (5)

Country Link
US (1) US20250057764A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452230A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024545816A (cg-RX-API-DMAC7.html)
CN (1) CN118414148A (cg-RX-API-DMAC7.html)
WO (1) WO2023119093A1 (cg-RX-API-DMAC7.html)

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3994974A (en) 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
SE378109B (cg-RX-API-DMAC7.html) 1972-05-19 1975-08-18 Bofors Ab
US4187301A (en) 1978-04-05 1980-02-05 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
BE887518A (fr) 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
CY1359A (en) 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
ZW6584A1 (en) 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US5707634A (en) 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9404080L (sv) 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
GB9413202D0 (en) 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
AU706195B2 (en) 1995-04-14 1999-06-10 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US5833891A (en) 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
US5886200A (en) 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6010935A (en) 1997-08-21 2000-01-04 Micron Technology, Inc. Self aligned contacts
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
NZ500555A (en) 1999-08-02 2000-11-24 Hovione Int Ltd Process for the preparation of mometasone furoate
DE60025019T2 (de) 1999-10-29 2006-08-24 Nektar Therapeutics, San Carlos Trockenpulverzusammensetzungen mit verbesserter dispersivität
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
WO2005000267A2 (en) 2003-05-28 2005-01-06 Nektar Therapeutics Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
AU2006272438B2 (en) 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
CN100560598C (zh) 2005-07-26 2009-11-18 上海奥锐特国际贸易有限公司 氟替卡松丙酸酯的合成方法
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
PT2435025T (pt) 2009-05-29 2016-11-11 Pearl Therapeutics Inc Administração, por via respiratória, de agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2013072938A2 (en) 2011-11-09 2013-05-23 Mylan Laboratories Ltd An improved process for the preparation of roflumilast
WO2014060464A1 (en) 2012-10-17 2014-04-24 Interquim, S.A. Process for preparing roflumilast
WO2014190204A1 (en) * 2013-05-22 2014-11-27 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of three or more active agents
US20230080276A1 (en) * 2020-02-20 2023-03-16 Chiesi Farmaceutici S.P.A. Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation

Similar Documents

Publication Publication Date Title
JP2024525555A5 (cg-RX-API-DMAC7.html)
JP2024527348A5 (cg-RX-API-DMAC7.html)
JP2024525567A5 (cg-RX-API-DMAC7.html)
HRP20240753T1 (hr) Pripravci, postupci i sustavi za otpuštanje aerosolne djelatne tvari
HRP20200298T1 (hr) Pripravci za respiratorno davanje aktivnih sredstava i pripadajući postupci i sustavi
JP2012528792A5 (cg-RX-API-DMAC7.html)
US20150150787A1 (en) Compositions, methods & systems for respiratory delivery of three or more active agents
JP2012528200A5 (cg-RX-API-DMAC7.html)
HRP20140864T1 (hr) Kombinacije koje sadrže antimuskarinska sredstva i beta-adrenergiäśke agoniste
JP2002538110A (ja) 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
CN104955448A (zh) 适用于吸入治疗的包含多组分结晶颗粒的药物组合物
TWI399202B (zh) 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
CN117915893A (zh) 用于气溶胶药物递送的组合物、方法和系统
US20250057764A1 (en) Compositions, methods and systems for aerosol drug delivery
JP2011509936A (ja) 吸入薬物製品、システムおよび使用
TW202600124A (zh) 一種吸入性醫藥製劑、裝置及其用途
BR102012027127A2 (pt) Composição contida em um inalador farmacêutico pressurizado com medidores de dosagem
HK40093100A (en) Compositions, methods and systems for aerosol drug delivery
HK40093100B (en) Compositions, methods and systems for aerosol drug delivery
HK40096570A (en) Compositions, methods and systems for aerosol drug delivery
HK40110160A (en) Compositions, methods and systems for aerosol drug delivery
HK40109490A (en) Compositions, methods and systems for aerosol drug delivery
WO2023128916A1 (en) An apparatus with a grid (10) for the preparation of dry powder compositions for inhalation
WO2022146257A1 (en) A process for the preparation of dry powder compositions for inhalation